Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Methods for detecting estrone by mass spectrometry

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Publication Date:
    September 24, 2019
  • معلومة اضافية
    • Patent Number:
      10422,804
    • Appl. No:
      15/616657
    • Application Filed:
      June 07, 2017
    • نبذة مختصرة :
      Provided are methods for determining the amount of estrone in a sample using mass spectrometry. The methods generally involve ionizing estrone in a sample and detecting and quantifying the amount of the ion to determine the amount of estrone in the sample.
    • Inventors:
      Quest Diagnostics Investments Incorporated (Wilmington, DE, US)
    • Assignees:
      Quest Diagnostics Investments Incorporated (Wilmington, DE, US)
    • Claim:
      1. A method for determining the amount of estrone in a sample, said method comprising: (a) adding deuterated estrone to a sample; (b) derivatizing estrone to produce a derivative of estrone; (c) purifying the sample by high performance liquid chromatography (HPLC); (d) ionizing the derivative of estrone and deuterated estrone in said sample with electrospray ionization (ESI) in positive ion mode to produce one or more ions detectable by mass spectrometry; (e) detecting the amount of the ions by tandem mass spectrometry; and (f) comparing the amount of said one or more ions of estrone and said one or more ions of deuterated estrone to determine the amount of estrone in the sample.
    • Claim:
      2. The method of claim 1 , wherein said deuterated estrone is d 4 -estrone.
    • Claim:
      3. The method of claim 1 , wherein said deuterated estrone is 2,4,16,16-d 4 estrone.
    • Claim:
      4. The method of claim 1 , wherein said method further comprises subjecting estrone from said sample to an extraction.
    • Claim:
      5. The method of claim 1 , wherein said method has a limit of quantitation less than or equal to 20 pg/mL.
    • Claim:
      6. The method of claim 1 , wherein said method has a limit of detection less than or equal to 10 pg/mL.
    • Claim:
      7. The method of claim 1 , wherein said sample is a human plasma or serum sample.
    • Claim:
      8. A method for determining the amount of estrone in a sample, said method comprising: (a) adding deuterated estrone to a sample; (b) derivatizing estrone to produce a derivative of estrone; (c) purifying the sample by liquid chromatography; (d) ionizing derivatized estrone and deuterated estrone in said sample with electrospray ionization (ESI) in positive ion mode to produce one or more ions detectable by mass spectrometry; (e) detecting the amount of the ions by tandem mass spectrometry; and (f) comparing the amount of said one or more ions of estrone and said one or more ions of deuterated estrone to determine the amount of estrone in the sample.
    • Claim:
      9. The method of claim 8 , wherein said liquid chromatography comprises high turbulence liquid chromatography (HTLC).
    • Claim:
      10. The method of claim 8 , wherein said liquid chromatography comprises high performance liquid chromatography (HPLC).
    • Claim:
      11. The method of claim 8 , wherein said deuterated estrone is d 4 -estrone.
    • Claim:
      12. The method of claim 8 , wherein said deuterated estrone is 2,4,16,16-d 4 estrone.
    • Claim:
      13. The method of claim 8 , wherein said method further comprises subjecting estrone from said sample to an extraction.
    • Claim:
      14. The method of claim 8 , wherein said method has a limit of quantitation less than or equal to 20 pg/mL.
    • Claim:
      15. The method of claim 8 , wherein said method has a limit of detection less than or equal to 10 pg/mL.
    • Claim:
      16. The method of claim 8 , wherein said sample is a human plasma or serum sample.
    • Claim:
      17. A method for determining the amount of estrone in a sample, said method comprising: (a) adding deuterated estrone to a sample; (b) derivatizing estrone to produce a derivative of estrone; (c) ionizing derivatized estrone and deuterated estrone in said sample with electrospray ionization (ESI) in positive ion mode to produce one or more ions detectable by mass spectrometry; (e) detecting the amount of the ions by tandem mass spectrometry; and (e) comparing the amount of said one or more ions of estrone and said one or more ions of deuterated estrone to determine the amount of estrone in the sample.
    • Claim:
      18. The method of claim 17 , wherein said deuterated estrone is d 4 -estrone.
    • Claim:
      19. The method of claim 17 , wherein said deuterated estrone is 2,4,16,16-d 4 estrone.
    • Claim:
      20. The method of claim 17 , wherein said method further comprises subjecting estrone from said sample to an extraction.
    • Claim:
      21. The method of claim 17 , wherein said method has a limit of quantitation less than or equal to 20 pg/mL.
    • Claim:
      22. The method of claim 17 , wherein said method has a limit of detection less than or equal to 10 pg/mL.
    • Claim:
      23. The method of claim 17 , wherein said sample is a human plasma or serum sample.
    • Patent References Cited:
      5772874 June 1998 Quinn et al.
      5795469 August 1998 Quinn et al.
      5919368 July 1999 Quinn et al.
      5968367 October 1999 Quinn et al.
      6107623 August 2000 Bateman et al.
      6124137 September 2000 Hutchens et al.
      6204500 March 2001 Whitehouse et al.
      6268144 July 2001 Koester
      7473560 January 2009 Soldin
      7618827 November 2009 Soldin
      8916385 December 2014 Goldman et al.
      9678087 June 2017 Goldman
      2003/0092601 May 2003 Polansky
      2004/0235193 November 2004 Soldin
      2006/0040256 February 2006 Caulfield et al.
      2006/0105408 May 2006 Hazen et al.
      2007/0043441 February 2007 Pisharodi
      2001116736 April 2001
      2003090839 March 2003
      2005283380 October 2005
      2006107339 October 2006
      2007044153 April 2007
      2007092873 August 2007
      2007139956 December 2007

















































    • Other References:
      Adlercreutz G., et al., “Mass Fragmentographic Determination of Eleven Estrogens in the Body Fluids of Pregnant and Nonpregnant Subjects,” Journal of Steroid Biochemistry, 1974, vol. 5, pp. 211-217. cited by applicant
      Bartolucci G., et al., “Liquid Chromatography Tandem Mass Spectrometric Quantitation of Sulfamethazine and its Metabolites: Direct Analysis of Swine Urine by Triple Quadrupole and by Ion Trap Mass Spectrometry,” Rapid Communications in Mass Spectrometry, 2000, vol. 14 (11), pp. 967-973. cited by applicant
      De-Alda M.J.L., et al., “Review of Analytical Methods for the Determination of Estrogens and Progestogens in Waste Waters,” Fresenius Journal of Analytical Chemistry, 2001, vol. 371, pp. 437-447. cited by applicant
      Diaz-Cruz M.S., et al., “Determination of Estrogens and Progestogens by Mass Spectrometric Techniques (GC/MS, LC/MS and LC/MS/MS),” Journal of Mass Spectrometry , 2003, vol. 38 (9), pp. 917-923. cited by applicant
      Dorgan A.F., et al., “Measurement of Steroid Sex Hormones in Serum: A Comparison of Radioimmunoassay and Mass Spectrometry,” Steroids, 2002, vol. 67 (3-4), pp. 151-158. cited by applicant
      Extended European Search Report for Application No. 08859581.4, dated Feb. 25, 2011. cited by applicant
      Extended European Search Report for Application No. 14176286.4, dated Oct. 8, 2014, 10 pages. cited by applicant
      Final Office Action dated Oct. 12, 2010 for U.S. Appl. No. 12/002,314 filed Dec. 13, 2007. cited by applicant
      Final Office Action dated Jul. 21, 2011 for U.S. Appl. No. 12/002,314 filed Dec. 13, 2007. cited by applicant
      Guasch-Jane M.R., et al., “Liquid Chromatography with Mass Spectrometry in Tandem Mode Applied for the Identification of Wine Markers in Residues from Ancient Egyptian Vessels,” Analytical Chemistry, 2004, vol. 76 (6), pp. 1672-1677. cited by applicant
      Guo T., et al., “Steroid Profiles Using Liquid Chromatography-Tandem Mass Spectrometry with Atmospheric Pressure Photoionization Source,” Archives of Pathology & Laboratory Medicine, 2004, vol. 128 (4), pp. 469-475. cited by applicant
      Higashi T., et al., “Procedure for Increasing the Detection Responses of Estrogens in LC-MS Based on Introduction of a Nitrobenzene Moiety Followed by Electron Capture Atmospheric Pressure Chemical Ionization,” Analytical and Bioanalytical Chemistry, 2006, vol. 386 (3), pp. 658-665. cited by applicant
      Hobe G., et al., “Some New Aspects of 17alpha-Estradiol Metabolism in Man,” Steroids, 2002, vol. 67 (11), pp. 883-893. cited by applicant
      Hsu J.F., et al., “Evaluation of Electrospray Ionization and Atmospheric Pressure Chemical Ionization for Simultaneous Detection of Estrone and Its Metabolites using High-Performance Liquid Chromatography/Tandem Mass Spectrometry,” Journal of Chromatography B, Elsevier, 2007, vol. 860 (1), pp. 49-56. cited by applicant
      Inoue K., et al., “Application of Liquid Chromatography-Mass Spectrometry to the Quantification of Bisphenol A in Human Semen,” Journal of Chromatography B, 2002, vol. 773 (2), pp. 97-102. cited by applicant
      International Search Report for Application No. PCT/US2008/085282, dated Feb. 9, 2009, 2 Pages. cited by applicant
      Lagana A., et al., “Trace Analysis of Estrogenic Chemicals in Sewage Effluent Using Liquid Chromatography Combined With Tandem Mass Spectrometry,” Rapid Communications in Mass Spectrometry, 2000, vol. 14 (6), pp. 401-407. cited by applicant
      Le-Bail J.C., et al., “Conversion of Dehydroepiandrosterone Sulfate at Physiological Plasma Concentration into Estrogens in MCF-7 Cells,” Steroids, 2002, vol. 67 (13-14), pp. 1057-1064. cited by applicant
      Lin D.L., et al., “Chemical Derivatization and the Selection of Deuterated Internal Standard for Quantitative Determination-methamphetamine Example.” Journal of Analytical Toxicology, 2000, vol. 24 (4), pp. 275-280. cited by applicant
      Lopez De-Alda M.J., et al., “Liquid Chromatography-(Tandem) Mass Spectrometry of Selected Emerging Pollutants (Steroid Sex Hormones, Drugs and Alkylphenolic Surfactants) in the Aquatic Environment,” Journal of Chromatography B, 2003, vol. 1000 (1-2), pp. 503-526. cited by applicant
      Merchant M., et al., “Recent Advancements in Surface-Enhanced Laser Desorption/Ionization-Time of Flight-Mass Spectrometry,” Electrophoresis, 2000, vol. 21 (6), pp. 1164-1167. cited by applicant
      Michael S.E, “The Isolation of Albumin from Blood Serum or Plasma by Means of Organic Solvents,” Biochemical Journal, 1962, vol. 82 (1), pp. 212-218. cited by applicant
      Nachtigall L.E., et al., “Serum Estradiol-Binding Profiles in Postmenopausal Women Undergoing Three Common Estrogen Replacement Therapies: Associations with Sex Hormone-Binding globulin, Estradiol, and Estrone Levels,” Menopause, 2000, vol. 7 (4), pp. 243-250. cited by applicant
      Nelson R.E., et al., “Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Measurement of Estradiol and Estronein Human Plasma,” Clinical Chemistry, 2004, vol. 50 (2), pp. 373-384. cited by applicant
      Nelson R.W., et al., “Measurement of Serum Estradiol and Estrone by LC-MS/MS,” Clinical Chemistry, 2002, vol. 48 (6), pp. A132. cited by applicant
      Non-Final Office Action dated Jan. 6, 2011 for U.S. Appl. No. 12/002,314 filed Dec. 13, 2007. cited by applicant
      Non-Final Office Action dated Sep. 6, 2013 for U.S. Appl. No. 12/002,314 filed Dec. 13, 2007. cited by applicant
      Non-Final Office Action dated Oct. 18, 2016 for U.S. Appl. No. 14/533,602 filed Nov. 5, 2014. cited by applicant
      Non-Final Office Action dated Jan. 22, 2016 for U.S. Appl. No. 14/063,956 filed Oct. 25, 2013. cited by applicant
      Non-Final Office Action dated May 25, 2010 for U.S. Appl. No. 12/002,314 filed Dec. 13, 2007. cited by applicant
      Non-Final Office Action dated Mar. 28, 2014 for U.S. Appl. No. 12/002,314 filed Dec. 13, 2007. cited by applicant
      Polson C., et al., “Optimization of Protein Precipitation Based Upon Effectiveness of Protein Removal and Ionization Effect in Liquid Chromatography-Tandem Mass Spectrometry,” Journal of Chromatography B, 2003, vol. 785 (2), pp. 263-275. cited by applicant
      Program & Abstract, The Endocrine Society's 89Th Annual Meeting, ENDO 07 Jun. 2-5, The Endocrine Society, 2007, pp. 1-344. cited by applicant
      Robb D.B., et al., “Atmospheric Pressure Photoionization: An Ionization Method for Liquid Chromatography- Mass Spectrometry,” Analytical Chemistry, 2000, vol. 72 (15), pp. 3653-3659. cited by applicant
      Salm P., et al., “The Quantification of Sirolimus by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Microparticle Enzyme Immunoassay in Renal Transplant Recipients,” Clinical Therapeutics, 2000, vol. 22 Suppl B, pp. B71-B85. cited by applicant
      Seifert M., et al., “A New Concept for the Bioeffects-Related Analysis of Xenoestrogens: Hyphenation of Receptor Assays with LC-MS,” Fresenius Journal of Analytical Chemistry, 1999, vol. 363 (8), pp. 767-770. cited by applicant
      Snedden W., et al., “The Direct Determination of Oestrogen and Progesterone in Human Ovarian Tissue by Quantitative High Resolution Mass Spectrometry,” Biomedical Mass Spectrometry, 1976, vol. 3 (6), pp. 295-298. cited by applicant
      Supplementary European Search Report for Application No. EP08859581, dated Feb. 25, 2011, 6 pages. cited by applicant
      Taylor P.J., et al., “Simultaneous Quantification of Tacrolimus and Sirolimus in Human Blood, by High-Performance Liquid Chromatography—Tandem Mass Spectrometry,” Therapeutic Drug Monitoring, 2000, vol. 22 (5), pp. 608-612. cited by applicant
      Wright Jr., G.L., et al., “Proteinchip Surface Enhanced Laser Desorption/Ionization (SELDI) Mass Spectrometry: A Novel Protein Biochip Technology for Detection of Prostate Cancer Biomarkers in Complex Protein Mixtures,” Prostate Cancer and Prostatic Diseases, 1999, vol. 2 (5-6), pp. 264-276. cited by applicant
      Written Opinion for Application No. PCT/US08/85282, dated Feb. 9, 2009, 4 Pages. cited by applicant
      Xia Y.Q., et al., “Trace Level Quantification of Deuterated 17[beta]-estradiol and Estrone in Ovariectomized Mouse Plasma and Brain Using Liquid Chromatography/tandem Mass Spectrometry Following Dansylation Reaction,” Rapid Communications in Mass Spectrometry, 2004, vol. 18 (14), pp. 1621-1628. cited by applicant
      Xu X., et al., “A Liquid Chromatography-Mass Spectrometry Method for the Quantitative Analysis of Urinary Endogenous Estrogen Metabolites,” Nature Protocols, 2007, vol. 2 (6), pp. 1350-1355. cited by applicant
      Xu X., et al., “Measuring Fifteen Endogenous Estrogens Simultaneously in Human Urine by High-Performance Liquid Chromatography-Mass Spectrometry,” Analytical Chemistry, 2005, vol. 77 (20), pp. 6646-6654. cited by applicant
      Xu X., et al., “Quantitative Measurement of Endogenous Estrogens and Estrogen Metabolites in Human Serum by Liquid Chromatography-Tandem Mass Spectrometry,” Analytical Chemistry, ACS Publications, 2007, vol. 79 (20), pp. 7813-7821. cited by applicant
      Yamashita K., et al., “Highly Sensitive Determination of Estrone and Estradiol in Human Serum by Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry,” Steroids, 2007, vol. 72 (11-12), pp. 819-827. cited by applicant
      Yan Q., et al., “Determination of Anabolic Hormones Multi-residues in Animal Muscle Tissues Using Liquich Chromatography-Tandem Mass Spectrometry,” Chinese Journal of Analytical Chemistry, 2006, vol. 34 (3), pp. 298-302. cited by applicant
      Zimmer D., et al., “Comparison of Turbulent-Flow Chromatography with Automated Solid-Phase Extraction in 96-Well Plates and Liquid-Liquid Extraction Used as Plasma Sample Preparation Techniques for Liquid Chromatography-Tandem Mass Spectrometry,” Journal of Chromatography A, 1999, vol. 854, pp. 23-35. cited by applicant
      European Search Report for Application No. 17203354.0 dated Mar. 1, 2018, 12 pages. cited by applicant
      Extended European Search Report for Application No. EP18176001, dated Jul. 4, 2018, 9 pages. cited by applicant
    • Primary Examiner:
      Hixson, Christopher Adam
    • Attorney, Agent or Firm:
      Quest Diagnostics
    • الرقم المعرف:
      edspgr.10422804